JENNIFER CALDER: Open Payments
NPI 1235714270 · BOERNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,372 in 41 payments from 12 companies in 2025. Trend: 2023 $23 · 2024 $893 · 2025 $1,372
Food & beverage: $1,372
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $384 |
| E.R. Squibb & Sons, L.L.C. | 3 | $270 |
| Teva Pharmaceuticals USA, Inc. | 10 | $187 |
| Neurocrine BioSciences, Inc. | 6 | $136 |
| KYOWA KIRIN, INC. | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Lundbeck LLC | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Alkermes, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
Products named: CAPLYTA, COBENFY, UZEDY, INGREZZA, CRYSVITA, FANAPT, REXULTI, Auvelity.
Industry payments across TX — which companies pay providers there.
